SOURCE: Salus Labs

June 24, 2011 11:19 ET

Salus Labs International Evaluates Solar Products Market

LAS VEGAS, NV--(Marketwire - Jun 24, 2011) - Salus Labs International, Inc. (PINKSHEETS: IPEX) announced today it has spent the past few months evaluating certain areas of the solar products marketplace. The Company has specifically focused on products that can play an immediate role in a variety of end-user markets, are very cost effective, have immediate revenue potential, and don't appear to require federal subsidies to support their existence and user demand. The Company expects to complete its evaluation in the coming weeks and hopes to add these products, which could provide immediate revenue and profits, to the Company's business activities. The Company will provide more information to its shareholders about this opportunity and the products if its efforts are successful.

About Salus Labs, International, Inc.
Salus Labs, International, Inc., a Nevada Corporation, has been focused primarily on the research, development, production, and marketing of high-quality nutritional supplements and anti-aging products and has recently expanded its attention to certain solar products. It currently trades on the OTC Markets as IPEX.PK.

Notice on Forward-Looking Statements:

The matters set forth in this press release may contain forward-looking statements regarding Salus Labs and its business within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date on which they are made and Salus Labs undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Statements are subject to risks and uncertainties that may cause actual results to differ materially.

Contact Information

  • For Information Contact:

    Investor Relations
    Gary Patterson